SEC Contract Filing

Filing Date: 2021-06-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>rtsl_ex102.htm
<DESCRIPTION>TRADING AGREEMENT
<TEXT>
<HTML>
<head><title>Trading Agreement</title> </head> <body> <div style="WIDTH:468pt; MARGIN-LEFT:72pt"> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=center><b>TRADING AGREEMENT</b></p> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px; TEXT-INDENT:36pt" align=justify><b>THIS TRADING AGREEMENT</b> (this &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Agreement</b></font>&#148;), made as of this 22<sup>nd</sup> day of April 2021 (the &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Effective</b><b> </b><b>Date</b></font>&#148;), by and among We the 23, LLC, at Texas limited liability company and its managing member, Charles L. Powell, M.D., an individual (<b>collectively</b> &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Shareholder</b></font>&#148;) and Rapid Therapeutic Science Laboratories, Inc., a Nevada corporation (RTSL) (the &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Company</b></font>&#148;).</p> <p style="FONT:12pt Times New Roman; MARGIN:0px">&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=center><b>W I T N E S S E TH:</b></p> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=center>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px; TEXT-INDENT:36pt" align=justify><b>WHEREAS</b>, the Shareholder is eligible to earn certain shares of convertible preferred stock of the Company pursuant to the terms of that certain Independent Contractor Agreement with the Company dated on or around the date hereof (the &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Preferred</b><b> </b><b>Stock</b></font>&#148;, and together with any and all other shares of common stock or other securities of the Company which a Shareholder may obtain beneficial or record ownership of until the end of the Trading Period (defined below), the &#147;<font style="BORDER-BOTTOM:#000000 1px solid"><b>Shares</b></font>&#148;, including, but not limited to the shares of common stock issuable upon conversion of such convertible preferred stock and any shares obtained by exercising warrants, or converting convertible securities and/or preferred stock, which Shares shall be subject to the terms of this Agreement as provided below); and</p> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px; TEXT-INDENT:36pt" align=justify><b>WHEREAS</b>, the parties hereto desire to enter into this Agreement upon the terms and conditions contained hereinafter to set forth conditions pursuant to which the Shareholder may transfer and sell the Shares.</p> <p style="FONT:12pt Times New Roman; MARGIN:0px" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px; TEXT-INDENT:36pt" align=justify><b>NOW, THEREFORE</b>, in consideration of the mutual premises set forth herein, $10 and <a name=_Hlk51233927>for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by Shareholder, the parties hereto hereby agree as follows.</p> <p style="FONT:12pt Times New Roman; MARGIN:0px">&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px; TEXT-INDENT:36.7pt" align=justify><b>1. &nbsp;</b><font style="BORDER-BOTTOM:#000000 1px solid"><b>Trading</b><b> </b><b>Period</b></font><b>.</b> Shareholder hereby agrees that:</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 36.7pt" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 36pt; TEXT-INDENT:36pt" align=justify><a name=_Ref42703871><a name=_Ref497471095><b>1.1. &nbsp;</b>Until April 22, 2025, Shareholder will not, directly or indirectly Transfer <font style="BORDER-BOTTOM:#000000 1px solid">any</font> of the Shares; provided that after April 22, 2023, and until April 22, 2025 (such period, the <font style="BORDER-BOTTOM:#000000 1px solid"><b>Trading</b><b> </b><b>Period</b></font>&#148;), Shareholder shall be authorized to sell a limited number of Shares in connection with an open market sale of the Shares, which number of Shares sold in the open market shall not exceed, on a daily basis, more than:</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 72pt" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 72pt" align=justify>(1) &nbsp;5.0% of the average aggregate daily number of shares of the Company&#146;s common stock which have traded publicly on the OTC Pink Market, OTCQB, or such other market or exchange on which the Company&#146;s common stock primarily trades, relative to the volume of shares trading during the open market (daily trading volume) (as adjusted for any stock split, recapitalization or combination), as determined by the daily trading volume of the open market for the preceding rolling thirty days.</p> <hr style="BORDER-TOP:0px; HEIGHT:0px; BORDER-RIGHT:0px; WIDTH:0px; BORDER-BOTTOM:0px; MARGIN:14pt 0px 0px; BORDER-LEFT:0px"> <p style="FONT:9pt Times New Roman; MARGIN:0px" align=center>Trading Agreement (a/k/a Lock-up and Leak-out Agreement)</p> <p style="FONT:9pt Times New Roman; MARGIN:0px" align=center>Powell and Rapid </p> <p style="FONT:9pt Times New Roman; MARGIN:0px" align=center>Page 1 of 6</p> <hr style="BORDER-TOP:0px; HEIGHT:3pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PAGE-BREAK-AFTER:always; MARGIN:8pt 0px; BORDER-LEFT:0px; BACKGROUND-COLOR:#909090"> <p style="MARGIN:0px; LINE-HEIGHT:0"> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 36pt; TEXT-INDENT:36pt" align=justify><a name=_Ref48557389><b>1.2. &nbsp;</b>Additionally, during the Trading Period:</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 72pt" align=justify>&nbsp;</p> <p style="FONT:12pt Times New Roman; MARGIN:0px 0px 0px 72pt" align=justify>(1) &nbsp;Shareholder will not engage in collectively selling of individual, isolated trades of Shares